...
search icon
lsta-img

Lisata Therapeutics Inc. Share Price

LSTA
NAQ
$4.11
+$0.05
(1.23%)
1D
Industry: Biotechnology Sector: Health Care

Lisata Therapeutics Inc. Analyst Forecast

Lisata Therapeutics Inc. Share Price Chart

Lisata Therapeutics Inc. Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$35.81M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
191.50K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.11
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.81 L
$4.17 H
$4.11

About Lisata Therapeutics Inc., Common Stock

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey. more

Industry: BiotechnologySector: Health Care

Lisata Therapeutics Inc. Stock Returns

Time FrameLSTASectorS&P500
1-Week Return90.28%1.64%-0.4%
1-Month Return98.55%2.13%0.14%
3-Month Return74.89%8.39%2.61%
6-Month Return55.09%16.16%8.7%
1-Year Return69.14%9.86%13%
3-Year Return12.91%17.8%72.1%
5-Year Return-88.03%33.74%79.31%
10-Year Return-95.62%135.48%268.2%

Lisata Therapeutics Inc. Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue--121.37M-1.00M[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":0.82,"profit":true}]
Cost of Revenue63.00K55.00K69.00K189.00K174.00K[{"date":"2020-12-31","value":33.33,"profit":true},{"date":"2021-12-31","value":29.1,"profit":true},{"date":"2022-12-31","value":36.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":92.06,"profit":true}]
Gross Profit(63.00K)(55.00K)63.77M(189.00K)1.00M[{"date":"2020-12-31","value":-0.1,"profit":false},{"date":"2021-12-31","value":-0.09,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-0.3,"profit":false},{"date":"2024-12-31","value":1.57,"profit":true}]
Gross Margin--52.54%-100.00%[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":52.54,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses19.14M29.05M57.60M25.71M23.41M[{"date":"2020-12-31","value":33.24,"profit":true},{"date":"2021-12-31","value":50.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":44.63,"profit":true},{"date":"2024-12-31","value":40.64,"profit":true}]
Operating Income(19.14M)(29.05M)(57.60M)(25.71M)(22.41M)[{"date":"2020-12-31","value":-1914500000,"profit":false},{"date":"2021-12-31","value":-2905000000,"profit":false},{"date":"2022-12-31","value":-5760100000,"profit":false},{"date":"2023-12-31","value":-2570800000,"profit":false},{"date":"2024-12-31","value":-2240900000,"profit":false}]
Total Non-Operating Income/Expense-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Pre-Tax Income(19.01M)(28.97M)(56.70M)(23.17M)(20.78M)[{"date":"2020-12-31","value":-1901300000,"profit":false},{"date":"2021-12-31","value":-2897400000,"profit":false},{"date":"2022-12-31","value":-5670400000,"profit":false},{"date":"2023-12-31","value":-2317000000,"profit":false},{"date":"2024-12-31","value":-2078300000,"profit":false}]
Income Taxes(10.87M)(1.51M)(2.48M)(2.33M)(798.00K)[{"date":"2020-12-31","value":-1087200000,"profit":false},{"date":"2021-12-31","value":-150800000,"profit":false},{"date":"2022-12-31","value":-247900000,"profit":false},{"date":"2023-12-31","value":-233000000,"profit":false},{"date":"2024-12-31","value":-79800000,"profit":false}]
Income After Taxes-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(8.14M)(27.47M)(54.23M)(20.84M)(19.98M)[{"date":"2020-12-31","value":-814100000,"profit":false},{"date":"2021-12-31","value":-2746600000,"profit":false},{"date":"2022-12-31","value":-5422500000,"profit":false},{"date":"2023-12-31","value":-2084000000,"profit":false},{"date":"2024-12-31","value":-1998500000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(8.15M)(27.47M)(54.23M)(20.84M)(19.98M)[{"date":"2020-12-31","value":-815000000,"profit":false},{"date":"2021-12-31","value":-2746600000,"profit":false},{"date":"2022-12-31","value":-5422500000,"profit":false},{"date":"2023-12-31","value":-2084000000,"profit":false},{"date":"2024-12-31","value":-1998500000,"profit":false}]
EPS (Diluted)(6.75)(7.80)(11.34)(2.58)(2.40)[{"date":"2020-12-31","value":-675,"profit":false},{"date":"2021-12-31","value":-780,"profit":false},{"date":"2022-12-31","value":-1134,"profit":false},{"date":"2023-12-31","value":-258,"profit":false},{"date":"2024-12-31","value":-240,"profit":false}]

Lisata Therapeutics Inc. Ratios

Lisata Therapeutics Inc. Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

LSTA
Cash Ratio 4.16
Current Ratio 4.72

Lisata Therapeutics Inc. Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

LSTA
ROA (LTM) -41.86%
ROE (LTM) -72.17%

Lisata Therapeutics Inc. Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

LSTA
Debt Ratio Lower is generally better. Negative is bad. 0.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.80

Lisata Therapeutics Inc. Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

LSTA
Trailing PE NM
Forward PE NM
P/S (TTM) 33.47
P/B 2.07
Price/FCF NM
EV/R 13.15
EV/Ebitda 0.82

FAQs

What is Lisata Therapeutics Inc. share price today?

Lisata Therapeutics Inc. (LSTA) share price today is $4.11

Can Indians buy Lisata Therapeutics Inc. shares?

Yes, Indians can buy shares of Lisata Therapeutics Inc. (LSTA) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in LSTA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Lisata Therapeutics Inc. be purchased?

Yes, you can purchase fractional shares of Lisata Therapeutics Inc. (LSTA) via the Vested app. You can start investing in Lisata Therapeutics Inc. (LSTA) with a minimum investment of $1.

How to invest in Lisata Therapeutics Inc. shares from India?

You can invest in shares of Lisata Therapeutics Inc. (LSTA) via Vested in three simple steps:

  • Click on Sign Up or Invest in LSTA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Lisata Therapeutics Inc. shares
What is Lisata Therapeutics Inc. 52-week high and low stock price?

The 52-week high price of Lisata Therapeutics Inc. (LSTA) is $4.17. The 52-week low price of Lisata Therapeutics Inc. (LSTA) is $1.81.

What is Lisata Therapeutics Inc. price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Lisata Therapeutics Inc. (LSTA) is

What is Lisata Therapeutics Inc. price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Lisata Therapeutics Inc. (LSTA) is 2.07

What is Lisata Therapeutics Inc. dividend yield?

The dividend yield of Lisata Therapeutics Inc. (LSTA) is 0.00%

What is the Market Cap of Lisata Therapeutics Inc.?

The market capitalization of Lisata Therapeutics Inc. (LSTA) is $35.81M

What is Lisata Therapeutics Inc.'s stock symbol?

The stock symbol (or ticker) of Lisata Therapeutics Inc. is LSTA

How Can Investors Use Lisata Therapeutics Inc. Share Price Data for Long-Term Investment Decisions?

Consider the share price of Lisata Therapeutics Inc. as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Lisata Therapeutics Inc. has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Lisata Therapeutics Inc. shares for Indian investors?

When investing in Lisata Therapeutics Inc. shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Lisata Therapeutics Inc. stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Lisata Therapeutics Inc. share price with other stocks in the same sector?

Rather than merely checking the share price of Lisata Therapeutics Inc. and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Lisata Therapeutics Inc. stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top